| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 60.6 | 58.8 | 29.3 |
| Other income | 1.3 | 0.3 | 1.3 |
| Total income | 61.9 | 59.1 | 30.6 |
| Profit before exceptional items & tax | 1.1 | 2.4 | 1.9 |
| Profit before tax | 1.1 | 2.4 | 1.9 |
| Net profit | 0.9 | 1.6 | 1.5 |
| Operating margin | 1.8% | 4.1% | 6.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -40.00% |
|---|---|
| Net profit, quarter on quarter | -43.80% |
| Revenue, year on year | +106.80% |
NSE results filing, NSE: AJOONI. Figures extracted from the filing.
Ajooni Biotech Ltd: key numbers
- Share price
- ₹3.05
- Market cap
- ₹52.53 Cr
- Revenue (annual)
- ₹182.4 Cr
- Net profit (annual)
- ₹4.32 Cr
- P/E (TTM)
- 13.3×Sector 28.6×
- Promoter holding
- 26.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajooni Biotech Ltd
All →Ajooni Biotech Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 50.0% YoY
Ajooni Biotech Ltd reported revenue from operations of ₹63.5 Cr (+102.9% YoY) and net profit of ₹0.4 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · -50.0% YoY
Ajooni Biotech Capital Structure Change
Ajooni Biotech has allotted 90 lakh equity shares to Healthy Biosciences Limited. The total issue value is ₹3.87 Crore.
- Value
- ₹3.87 Cr
Ajooni Biotech Board Meeting Date
Ajooni Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for the June 2026 quarter.
Ajooni Biotech Capital Structure Change
The company's shareholders approved an increase in its authorized share capital to ₹70 Crore at the 16th Annual General Meeting.
Ajooni Biotech Capital Structure Change
Ajooni Biotech received shareholder approval for the preferential issuance of 90,00,000 equity shares at Rs. 4.30 each, valued at approximately ₹3.87 Crore.
- Value
- ₹3.87 Cr
Ajooni Biotech Management Change
Ajooni Biotech shareholders approved the re-appointment of Mr. Gursimran Singh as Director at the 16th Annual General Meeting held on July 29, 2026.